From TechCrunch · Julie Bort · · 1m 10s
Angle Health hits $2.7B valuation with $200M Series C
Y Combinator insurance tech startup raises major funding round without AI focus, proving non-AI startups can still command big valuations.
In brief
Y Combinator insurance tech startup raises major funding round without AI focus, proving non-AI startups can still command big valuations. Angle Health's $2.7B valuation shows that profitable, non-AI startups solving real business problems can still raise significant capital and achieve unicorn status. Originally…
Angle Health reaches $2.7B valuation
The Y Combinator insurance tech startup raised $200 million in Series C funding alongside a $400 million employee tender offer, led by Vitruvian Partners.
What Angle Health actually does
The startup helps small businesses obtain and manage level-funded health plans, which sit between fully insured and self-funded options, offering predictable costs with potential savings.
AI-powered platform for small business
Angle Health's platform uses AI to help small businesses choose and manage plans, integrating with payroll and HR systems to streamline the process.
Serving 5,000 businesses profitably
Angle Health says it serves over 5,000 businesses and has already achieved profitability, a rare milestone for a startup founded in 2019.
Non-AI startup still commands big money
Angle Health's $2.7B valuation proves that startups not focused on AI agents can still raise substantial Series C funding and achieve unicorn status.
In short
Angle Health's $2.7B valuation shows that profitable, non-AI startups solving real business problems can still raise significant capital and achieve unicorn status.
